
"Eli Liy makes 53% versus a buy and hold of 49%. I think it's going to get up there to $900. I would consider buying around $825 with a bottom at $795 and a target around $900."
The analyst outlines a detailed trade call for a pharma stock, referred to as "Eli Liy" (assumed ticker LLY), suggesting an entry around $825 with a price target of $900 and a potential add-on near $795 if it dips further. The rationale is based on both technical gap fills and a change in valuation dynamics.
⚡ Alpha Picks Scalping Masterclass Fast Gains, Portfolio Management, & Q3’s Market Winners! 🚀📊
October 2, 2025
Stock Idea